Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov-Dec;1(4-5):213-20.
doi: 10.1242/dmm.000323.

Mouse models of allergic asthma: acute and chronic allergen challenge

Affiliations
Review

Mouse models of allergic asthma: acute and chronic allergen challenge

Anthony T Nials et al. Dis Model Mech. 2008 Nov-Dec.

Abstract

Asthma is defined as a chronic inflammatory disease of the airways; however, the underlying physiological and immunological processes are not fully understood. Animal models have been used to elucidate asthma pathophysiology, and to identify and evaluate novel therapeutic targets. Several recent review articles (Epstein, 2004; Lloyd, 2007; Boyce and Austen, 2005; Zosky and Sly, 2007) have discussed the potential value of these models. Allergen challenge models reproduce many features of clinical asthma and have been widely used by investigators; however, the majority involve acute allergen challenge procedures. It is recognised that asthma is a chronic inflammatory disease resulting from continued or intermittent allergen exposure, usually via inhalation, and there has been a recent focus on developing chronic allergen exposure models, predominantly in mice. Here, we review the acute and chronic exposure mouse models, and consider their potential role and impact in the field of asthma research.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alexander A. G., Barnes N. C., Kay A. B. (1992). Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339, 324–328 - PubMed
    1. Bartlett N. W., Walton R. P., Edwards M. R., Aniscenko J., Caramori G., Zhu J., Glanville N., Choy K. J., Jourdan P., Burnet J., et al. (2008). Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14, 199–204 - PMC - PubMed
    1. Blyth D. I., Pedrick M. S., Savage T. J., Hessel E. M., Fattah D. (1996). Lung inflammation and epithelial changes in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14, 425–438 - PubMed
    1. Blyth D. I., Wharton T. F., Pedrick M. S., Savage T. J., Sanjar S. (2000). Airway subepithelial fibrosis in a murine model of atopic asthma, suppression by dexamethasone or anti-IL-5 antibody. Am. J. Respir. Cell Mol. Biol. 23, 241–246 - PubMed
    1. Borish L. C., Nelson H. S., Lanz M. J., Claussen L., Whitmore J. B., Agosti J. M., Garrison L. (1999). Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo controlled trial. Am. J. Respir. Crit. Care Med. 160, 1816–1823 - PubMed